Latest News

• share
• favorite_border

Traumatic brain injury (TBI) is a leading cause of cognitive impairment that affects millions of people worldwide. Despite growing awareness about the debilitating and lifelong progressive consequences of TBI, there are currently no treatments that slow the deteriorative process. TBI survivors are currently treated with extensive physical and cognitive rehabilitation, accompanied by medications that may mitigate symptoms yet do not halt or slow neurodegeneration. Now, researchers have found for the first time that this process can be pharmacologically reversed in an animal model of this chronic health condition, offering an important proof of principle in the field and a potential path to new therapy.

• share
• favorite_border

UH has implemented PatientTrak, a virtual waiting room that enables the patient to communicate effectively with staff so they can arrive at their appointment on time while avoiding an in-person waiting room.

• share
• favorite_border

This month, University Hospitals (UH) Harrington Heart & Vascular Institute became the first hospital in the U.S. to use the new blood retrieval device ProCell®.

• share
• favorite_border

The Cardiometabolic Center Alliance (CMCA), founded by Saint Luke’s Mid America Heart Institute is pleased to announce the addition of University Hospitals Cleveland Medical Center as Key Strategic Partner and Charter Member. As a coalition that seeks to establish Cardiometabolic Centers of Excellence nationwide aimed at transforming the treatment of type 2 diabetes (T2D) and related cardiovascular (CV) and renal comorbidities, the CMCA considers University Hospitals (UH) a large integrated health system based in Cleveland, Ohio a key member of the Alliance.

• share
• favorite_border

Announcement of the 2021 Harrington UK Rare Disease Scholar Award recipients, their organizations and fields of research: Pietro Fratta, MD, PhD – University College London Gene Therapy for Kennedy’s Disease, a rare neuromuscular disease Angela Russell, DPhil – University of Oxford New Drugs for the Treatment of Duchenne Muscular Dystrophy Helen Waller-Evans, DPhil – Cardiff University Novel Inhibitors to Treat Multiple Lysomal Storage Disorders, causes of widespread organ damage Wyatt Yue, PhD – University of Oxford Inhibitors of Primary Hyperoxaluria, a cause of kidney failure Haiyan Zhou, MD, PhD – University College London Novel Therapy for SPTLC1-Related Hereditary Sensory Neuropathy, a cause of shooting pain

• share
• favorite_border

A patient at UH Cleveland Medical Center received an AAV8-mediated gene transfer of human Ornithine Transcarbamylase. The infusion was well tolerated and patient was discharged without issue. The gene therapy is part of an international, multi-site trial sponsored by Ultragenyx Pharmaceutical Inc.

• share
• favorite_border

Announcement that University Hospitals in Cleveland received a quality score of 97.4 percent for the 2019 performance year, and will receive $9.1 million in shared savings from Centers for Medicare and Medicaid Services (CMS).

• share
• favorite_border

Edward M. Barksdale, Jr., MD, Surgeon-in-Chief at University Hospitals Rainbow Babies & Children’s Hospital (UH Rainbow), has been named president-elect of the American Pediatric Surgery Association (APSA). Dr. Barksdale will be APSA’s 53rd President, and will begin his one year term of service in May 2021.

• share
• favorite_border

• share
• favorite_border

University Hospitals has named Timothy P. Kasprzak, MD, MBA, as Chief Medical Officer of UH Ahuja Medical Center. Dr. Kasprzak will begin his new appointment on Monday, November 2, 2020.

• share
• favorite_border

Surgeons at University Hospitals Cleveland Medical Center have improved the prognosis of several cardiac patients after emergency FDA approval of a diaphragm pacing device.

• share
• favorite_border

University Hospitals has launched a new hospital price estimator tool which provides patients with information about their estimated out-of-pocket costs for the most shoppable common services and procedures.

• share
• favorite_border

A study out of University Hospitals found that removing the cost barrier for coronary artery calcium screening resulted in an immediate increase in utilization of the test.

• share
• favorite_border

Announcement of Nicholas C. Bambakidis, MD, Vice President and Director of the Neurological Institute at University Hospitals in Cleveland, recent election as President-Elect of the Congress of Neurological Surgeons.

• share
• favorite_border

Announcement of a new gift of $10 million to establish the Wesley Center for Immunotherapy at University Hospitals Seidman Cancer Center in Cleveland.

• share
• favorite_border

An international taskforce of experts developed guidelines to help ER physicians triage patients presenting with dizzy symptoms using telemedicine.

• share
• favorite_border

University Hospitals Cleveland Medical Center is the first hospital in Ohio to receive the American Heart Association's four highest stroke care awards.

• share
• favorite_border

A variety of treatments exist to address heart disease, yet it continues to carry a poor prognosis. A new study from University Hospitals showed that a person’s address can help predict their chance of mortality from heart disease.

• share
• favorite_border

Announcement of University Hospitals plans to participate as a site for the Phase 2/3 global study sponsored by Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) of an investigational vaccine, BNT162b2, against SARS-CoV-2.

• share
• favorite_border

Air pollution is the world’s leading environmental risk factor, and causes more than nine million deaths per year. New research published in the Journal of Clinical Investigation shows air pollution may play a role in the development of cardiometabolic diseases, such as diabetes. Importantly, the effects were reversible with cessation of exposure.